about
High variability in glucocorticoid starting doses in patients with rheumatoid arthritis: observational data from an early arthritis cohort.Abatacept: the evidence for its place in the treatment of rheumatoid arthritis.The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor.Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials.Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy.A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical CentersIdentifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.Tight control in the treatment of rheumatoid arthritis: efficacy and feasibilityInflammatory arthritis: an overview for primary care physicians.Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry.Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort studyOptimizing the expediency of TNFi in rheumatoid arthritis: offering a TNFi holiday in patients having reached low-disease activity in the maintenance phase.N-feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis.Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis.Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.Validation of a prediction rule for the diagnosis of rheumatoid arthritis in patients with recent onset undifferentiated arthritis.Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats.Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.
P2860
Q30890060-05DD0577-091E-4F88-AE4B-1ACF6DAEB963Q34449851-205814BD-1A00-457C-AC97-C6F86B38353FQ35048356-9031F59C-3018-48B8-9E83-7B128A2B7763Q35555021-053D4CF9-313B-4FFE-B6E4-D1DBD751BBA4Q35661221-68102801-D433-4DAD-8732-8CC43151469AQ35760159-D0A2CBF4-841F-4AF8-916A-29FC60F9C1AFQ36013833-2FD71483-24BB-4E31-B0F1-67448CF7907CQ36810156-A329A4EA-0839-4B01-A577-C1AF4D71FD40Q36836531-87E5E3F4-7DA1-4F30-9A0E-9B9BDBC38C95Q36969898-62D99F43-8276-4883-BDAD-B1D0136F9D78Q37427257-55946E5F-0FA2-4DA1-B0EE-AC6E3C80D1AFQ37466558-BE23E473-5D8E-44B5-8A8F-C92CBF4EC3D4Q37709979-E9E062FD-D6C9-4674-A69C-17E026F34512Q38264653-8987B45B-C687-4132-835D-454F22460894Q39177048-4A3464F9-32EA-4448-AC7C-F27273C4107DQ41931049-D967433E-8A4C-40DB-AFC3-C31ABEBA2DE1Q43171700-64941C20-8596-47D9-9AD4-F68395568BA9Q43223531-16A5A478-86D2-424B-BB99-3E78B9FCBDB7Q45032600-A6071713-67F6-43FA-8D20-D3D00E5ABF5AQ47567355-0CC6F60C-FE91-47F8-8626-9ADE2C1AB519
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Therapeutic strategies in early rheumatoid arthritis.
@ast
Therapeutic strategies in early rheumatoid arthritis.
@en
type
label
Therapeutic strategies in early rheumatoid arthritis.
@ast
Therapeutic strategies in early rheumatoid arthritis.
@en
prefLabel
Therapeutic strategies in early rheumatoid arthritis.
@ast
Therapeutic strategies in early rheumatoid arthritis.
@en
P1476
Therapeutic strategies in early rheumatoid arthritis.
@en
P2093
Daniel Aletaha
Klaus P Machold
P304
P356
10.1016/J.BERH.2004.08.009
P577
2005-02-01T00:00:00Z